Pharmaceutial & Healthcare

 The global Pneumatic Conveying Systems Market subject to witness a substantial growth due to the growing adoption of advanced manufacturing methods and development of application specific and tailor-made products. The recent technological advancement in the manufacturing sector coupled with application specific automated devices to improve productivity in various end-user industry is expected to drive the growth of pneumatic conveying systems industry over the next seven years. Development of compact pressure-vessel conveying systems with intelligent control technology is expected to boost market demand over the next seven years. Use of pneumatic conveying systems helps to increase productivity and limits operation downtime, thereby propelling market growth. Pneumatic conveying systems also helps to enhance quality of end-product. Globally, the pneumatic conveying system market is predicted to grow at higher CAGR in the forecast period, providing numerous opportunities for market play

 Global transdermal drug delivery system market is anticipated to reach USD 81.4 billion by 2024 owing to shift toward sedentary lifestyle that encourages chronic disorders. Transdermal drug delivery is a painless process of delivering drug in the body part. TDDS delivers drug through the skin in pre-decided and regulated rate. It offers extended therapeutic effects, lesser side-effects, improved patient compliance, better bioavailability, and easy cessation of drug treatment. Transdermal drug delivery is much preferred today as compared to the conventional oral method or injectables. Transdermal drug delivery systems market is witnessing growth due to the factors like increasing consumer preference for minimally invasive procedures for chronic disorders and multiple advantages associated with TDDS. Infusion of drug could be effectively monitored and projected creditably through transdermal drug delivery method, which makes it convenient to maintain steady level of drug. However, trans

 The global preimplantation genetic testing (PGD/PGT) market is expected to value at USD 221.1 million by 2024. The market is subject to witness a substantial growth due to the rising awareness in regards to genetic techniques and increasing adoption for detection of chromosomal abnormalities. Use of preimplantation genetic testing (PGD/PGS) for embryo screening to perform in vitro fertilization (IVF) is expected to boost market growth over the forecast period. Identification of genetic disorders and inherited conditions with the help of preimplantation genetic testing (PGT) and diagnosis is predicted to foster market growth over the upcoming years. Globally, the preimplantation genetic testing industry is predicted to grow at higher CAGR in the forecast period, providing numerous opportunities for market players to invest for research and development in the preimplantation genetic testing market. Early diagnosis of the chromosomal disorders helps to reduce the number of people sufferi